FDA Inspection 1089435 — ANI Pharmaceuticals, Inc.
The FDA completed an inspection of ANI Pharmaceuticals, Inc. on April 12, 2019 in Baudette, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 12, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Baudette, MN (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)